(Q74776188)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9663184%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

title

Serum sickness-like reaction to cefaclor: lack of in vitro cross-reactivity with loracarbef (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9663184%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

1 reference

Kearns GL

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9663184%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

Wheeler JG

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9663184%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

Rieder MJ

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9663184%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

Reid J

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9663184%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

publication date

1 June 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9663184%20AND%20SRC:MED&resulttype=core&format=json

Clinical Pharmacology & Therapeutics

13 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9663184%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

volume

63

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9663184%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

page(s)

686-693

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9663184%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9663184%20AND%20SRC:MED&resulttype=core&format=json

Formation of fluorescent pyrazine derivatives via a novel degradation pathway of the carbacephalosporin loracarbef

13 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990093-5

Anticonvulsant hypersensitivity syndrome. In vitro assessment of risk

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990093-5

Differences in metabolism of sulfonamides predisposing to idiosyncratic toxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990093-5

Severe adverse cutaneous reactions to drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990093-5

Pharmacokinetic disposition of loracarbef in healthy young men and women at steady state

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990093-5

10.1016/S0009-9236(98)90093-5

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9663184%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

1 reference